Evidence map›Paper›PMID 41826506›Full record

ArticleCommunications biology2026

An ontogeny-cytokine code determines macrophage response polarity and tumor outcomes.

Dominik J Schaer, Nadja Schulthess-Lutz, Matthias J Peterhans, Livio Baselgia, Melanie Eschment, Rok Humar, Florence Vallelian

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dominik J SchaerDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.
Nadja Schulthess-LutzDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2918-6262
Matthias J PeterhansDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3832-8637
Livio BaselgiaDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2583-8195
Melanie EschmentDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6881-6570
Rok HumarDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland.
Florence VallelianDepartment of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland. florence.vallelian@usz.ch.ORCID http://orcid.org/0000-0001-9659-8278

Funding

Krebsliga Schweiz (Ligue Suisse Contre le Cancer) KFS-5944-08-2023Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_201202/1
6 · The paper itself

Abstract

Tumor-associated macrophages can either promote or suppress cancer, but therapeutic targeting remains challenging because we lack a predictive framework for macrophage function. The prevailing M1/M2 paradigm oversimplifies how macrophage developmental origin (ontogeny) and local cytokines shape antitumor versus protumor behavior. We systematically map eight reference macrophage states by differentiating mouse bone marrow cells with M-CSF or GM-CSF and polarizing them with four key cytokines (IFN‑γ, IL‑4, IL‑10, TGF‑β). Using integrated transcriptomic profiling, 3D tumor spheroids, and experimental metastasis models, we find that macrophage ontogeny determines whether cytokines promote or suppress tumor progression. Most notably, IL-4 induces opposite effects depending on ontogeny: promoting tumor growth, invasion, and metastasis in M-CSF-derived macrophages, while suppressing these processes in GM-CSF-derived macrophages. A similar ontogeny-dependent divergence was observed for IL-10, whereas IFN-γ consistently exerted antitumor effects and TGF-β protumor effects across both lineages. These findings define an ontogeny‑cytokine interaction framework that determines macrophage function based on developmental origin and cytokine context. By identifying ontogeny as a key determinant of cytokine responses, this work provides a conceptual basis for more precise macrophage-directed cancer immunotherapy strategies.

Indexed as

Cell PolarityCytokinesMacrophagesNeoplasmsTumor-Associated MacrophagesAnimalsCell DifferentiationFemaleGranulocyte-Macrophage Colony-Stimulating FactorMacrophage Colony-Stimulating FactorMiceMice, Inbred C57BLCytokinesGranulocyte-Macrophage Colony-Stimulating FactorMacrophage Colony-Stimulating Factor

Identifiers

PMID41826506
PMCPMC13129106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.